All CIRM Grants

Institution Researcher name Grant Type Grant Title Award Value
Stanford University Samuel Strober Conference II Third International Workshop on Clinical Tolerance $29,500
University of California, Los Angeles Song Li Conference II The 18th Annual UC System-Wide Bioengineering Symposium $25,000
University of California, San Diego Karen Christman Therapeutic Translational Research Projects Injectable pro-regenerative scaffold for treating symptomatic peripheral artery disease $2,839,317
Stanford University Joseph Wu Tool Translational Research Projects A Novel, Robust and Comprehensive Predictive Tool Using Human Disease-Specific Induced Pluripotent Stem Cells for Preclinical Drug Screening $975,000
Cellular Biomedicine Group, Inc. Jack Wang Late Stage Preclinical Projects Allogenic human adipose-derived mesenchymal stem cells for the treatment of knee osteoarthritis $1,200,000
Caladrius Biosciences William Sietsema Clinical Trial Stage Projects Phase 2 Safety and Efficacy Study of CLBS03 Autologous T-Regulatory Cells in Adolescents with Recent Onset Type 1 Diabetes Mellitus $8,175,946
Cedars-Sinai Medical Center Clive Svendsen Clinical Trial Stage Projects Human Neural Progenitors Secreting Glial Cell Line-Derived Neurotrophic Factor (CNS10-NPC-GDNF) for the Treatment of Amyotrophic Lateral Sclerosis $6,154,067
St. Jude Children's Research Hospital Stephen Gottschalk Clinical Trial Stage Projects Lentiviral Gene Therapy for Infants with X-linked Severe Combined Immunodeficiency using Autologous Bone Marrow Stem Cells and Busulfan Conditioning $11,924,780
Stanford University Joseph Wu Conference II 2017 Stanford Drug Discovery and Stem Cell Technology Conference $2,359
City of Hope, Beckman Research Institute John Zaia Conference - The 2017 Alpha Stem Cell Clinic Annual Symposium 2nd Annual Symposium of the CIRM Alpha Stem Cell Clinics Network "Alpha Clinics - Making the Future a Reality for Stem Cell-Based Therapies" $79,287
Parkinson's Institute Birgitt Schuele Quest - Discovery Stage Research Projects CRISPR/dCas9 mutant targeting SNCA promoter for downregulation of alpha-synuclein expression as a novel therapeutic approach for Parkinson’s disease $1,288,415
University of California, San Diego Dan Kaufman Quest - Discovery Stage Research Projects Targeted off-the-shelf immunotherapy to treat refractory cancers $1,936,936
University of California, Los Angeles John Chute Quest - Discovery Stage Research Projects Protein tyrosine phosphatase - sigma inhibitors for hematopoietic regeneration $2,116,708
University of California, San Francisco Julie Sneddon Quest - Discovery Stage Research Projects Designing a cellular niche for transplantation of human embryonic stem cell-derived beta cells $2,006,076
Stanford University Matthew Porteus Quest - Discovery Stage Research Projects Genome Editing to Correct Cystic Fibrosis Mutations in Airway Stem Cells $1,968,456
University of California, San Diego Alysson Muotri Quest - Discovery Stage Research Projects A treatment for Zika virus infection and neuroprotection efficacy $1,924,524
Stanford University Rosa Bacchetta Quest - Discovery Stage Research Projects GENE EDITING FOR FOXP3 IN HUMAN HSC $984,228
University of California, San Francisco Tejal Desai Quest - Discovery Stage Research Projects Thin Film Encapsulation Devices for Human Stem Cell derived Insulin Producing Cells $1,092,063
Stanford University Roel Nusse Quest - Discovery Stage Research Projects Preclinical development of human hepatocyte progenitor cells for cell therapy $1,651,211
University of California, Irvine Leslie Thompson Quest - Discovery Stage Research Projects hNSC-mediated delivery of ApiCCT1 as a candidate therapeutic for Huntington’s disease $1,650,263
Gladstone Institutes, J. David Deepak Srivastava Quest - Discovery Stage Research Projects Direct Cardiac Reprogramming for Regenerative Medicine $2,392,157
jCyte, Inc Henry Klassen Clinical Trial Stage Projects Phase 2b Clinical Study of Safety and Efficacy of Intravitreal Injection of Retinal Progenitor Cells (jCell) for Treatment of Retinitis Pigmentosa $8,295,750
Stanford University Samuel Strober Clinical Trial Stage Projects Induction of Tolerance to Combined Kidney and Hematopoietic Progenitor Cell Transplants from HLA Haplotype Matched Living Donors $6,653,266
Ankasa Regenerative Therapeutics Ying Zhu Therapeutic Translational Research Projects An autologous somatic stem cell therapy for the treatment of osteonecrosis $2,088,780
University of Southern California Denis Evseenko Therapeutic Translational Research Projects Pluripotent stem cell-derived chondrocytes for articular cartilage repair $2,503,104
UCSF Benioff Children’s Hospital Oakland Mark Walters Therapeutic Translational Research Projects Curing Sickle cell Disease with CRISPR-Cas9 genome editing $4,394,276
Gladstone Institutes, J. David Yadong Huang Therapeutic Translational Research Projects Human iPSC-derived GABAergic Progenitors for Alzheimer’s Disease Treatment $1,900,000
University of California, San Francisco Mark Walters Therapeutic Translational Research Projects Curing Sickle cell Disease with CRISPR-Cas9 genome editing $60,635
City of Hope, Beckman Research Institute Paul Salvaterra Conference - Manage The SPARK Annual Meeting Manage the 2017 SPARK Annual Meeting $22,555
University of Southern California Justin Ichida Conference II The 7th Annual California ALS research network and PAC10 meeting $10,830
University of California, Los Angeles Donald Kohn Clinical Trial Stage Projects Efficacy and safety of cryopreserved autologous CD34+ HSC transduced with EFS lentiviral vector encoding for human ADA gene in ADA-SCID subjects $5,827,000
University of California, Los Angeles Donald Kohn Clinical Trial Stage Projects Efficacy and safety of cryopreserved autologous CD34+ HSC transduced with EFS lentiviral vector encoding for human ADA gene in ADA-SCID subjects $10,156,925
Cedars-Sinai Medical Center Michael Lewis Clinical Trial Stage Projects Pulmonary Arterial Hypertension Treated with Cardiosphere-Derived Allogeneic Stem Cells $7,354,772
Orchard Therapeutics plc Leslie Meltzer Clinical Trial Stage Projects Efficacy and safety of cryopreserved autologous CD34+ HSC transduced with EFS lentiviral vector encoding for human ADA gene in ADA-SCID subjects $2,638,745
San Diego State University Foundation Ralph Feuer Conference - Manage The Bridges Annual Meeting 2017 Bridges Annual Meeting $153,449
IQVIA, Inc. Eugene Brandon Translating Center A Translating Center designed to expedite the development and delivery of high quality stem cell therapies to patients $15,000,000
University of California, San Diego Stephanie Cherqui Late Stage Preclinical Projects Ex vivo transduced autologous human CD34+ hematopoietic stem cells for treatment of cystinosis $5,273,189
Midwinter Conference of Immunologists Christel Uittenbogaart Conference II The 2017 Midwinter Conference of Immunologists at Asilomar $5,000
University of California, San Diego Robert Sah Conference II 2016 Tissue Engineering and Regenerative Medicine International Society - Americas (TERMIS-AM) Conference in San Diego, CA on December 11-14, 2016 $40,000
Vitalant Research Institute Shibani Pati Conference II Cellular Therapies and Transfusion Medicine in Trauma and Critical Care - Looking Towards the Future $30,000
Alliance Forum Foundation George Hara Conference II 2016 World Alliance Forum in San Francisco (WAFSF) “US-Japan Innovative Healthcare Technologies Conference” $20,000
Humacyte, Inc. Jeffrey Lawson Clinical Trial Stage Projects A Human Acellular Vessel in Patients Needing Renal Replacement Therapy: A Comparison with ePTFE Grafts as Conduits for Hemodialysis (HUMANITY) $7,625,000
University of California, Los Angeles April Pyle Quest - Discovery Stage Research Projects CRISPR/Cas9 nanoparticle enabled therapy for Duchenne Muscular Dystrophy in muscle stem cells $2,150,400
Stanford University Hiromitsu Nakauchi Quest - Discovery Stage Research Projects Novel Rejuvenated T Cell Immunotherapy for Lung Cancer $1,968,456
University of California, Berkeley David Schaffer Quest - Discovery Stage Research Projects Scalable, Defined Production of Oligodendrocyte Precursor Cells to Treat Neural Disease and Injury $1,627,099
University of California, Davis David Segal Quest - Discovery Stage Research Projects MSC delivery of an artificial transcription factor to the brain as a treatment for Angelman Syndrome $1,055,319
Scripps Research Institute Jeanne Loring Quest - Discovery Stage Research Projects Autologous cell therapy for Parkinson’s disease using iPSC-derived DA neurons $2,299,786
Gladstone Institutes, J. David Deepak Srivastava Quest - Discovery Stage Research Projects Use of Human iPSC-derived Endothelial Cells for Calcific Aortic Valve Disease Therapeutics $2,400,048
California Institute of Technology David Baltimore Quest - Discovery Stage Research Projects Immunotherapy for HIV infection using engineered hematopoietic stem/progenitor cells $1,569,193
ViaCyte, Inc. Kevin D'Amour Late Stage Preclinical Projects Stem cell-derived islet cell replacement therapy with immunosuppression for high-risk type 1 diabetes $3,544,721
IQVIA, Inc. Peter Robinson Accelerating Center An Accelerating Center designed to expedite the development and delivery of high quality stem cell therapies to patients $11,772,453
University of California, Los Angeles Sophie Deng Late Stage Preclinical Projects Regeneration of a Normal Corneal Surface by Limbal Stem Cell Therapy $4,244,211
University of California, Los Angeles Brigitte Gomperts Conference - Lung Regenerative Medicine Workshop Stem Cells for Lung Diseases - Overcoming Barriers to Find New Therapies $44,548
University of California, San Francisco Andrew Brack Inception - Discovery Stage Research Projects Examining the efficacy of GDF11 antibody as a rejuvenator of aged human muscle stem cell capacity and muscle repair . $180,000
University of California, Los Angeles April Pyle Inception - Discovery Stage Research Projects Novel Platforms to Enhance In Vivo Delivery of Skeletal Muscle Progenitor Cells from Human Pluripotent Stem Cells $230,400
Stanford University Albert Wong Therapeutic Translational Research Projects 2nd Generation Vaccine for the Treatment of Glioblastoma $2,929,889
University of California, San Diego Alysson Muotri Inception - Discovery Stage Research Projects Reverse transcriptase inhibitors as a novel therapeutic approach for neurological autoimmune disorders $210,060
University of California, Los Angeles Owen Witte Inception - Discovery Stage Research Projects Identification of stem cell surface markers as potential therapeutic targets for advanced prostate cancer $209,160
Stanford University Jeffrey Goldberg Inception - Discovery Stage Research Projects Embryonic Stem Cells for Corneal Endothelial Degeneration $235,836
Vitalant Research Institute Marcus Muench Inception - Discovery Stage Research Projects Modulating Liver Sinusoidal Endothelial Cell Permeability to Enhance Engraftment of Endothelial Cell Progenitors for the Treatment of Hemophilia A $180,000
Children's Hospital of Los Angeles Senta Georgia Inception - Discovery Stage Research Projects Developing a personalized approach to beta cell replacement for patients with a genetic form of diabetes $179,995
University of California, San Diego Karl Wahlin Inception - Discovery Stage Research Projects Microenvironment based optimization of retinal induction using CRISPR-CAS9 reporter pluripotent stem cells as an expandable source of retinal progenitors and photoreceptors. $232,200
University of California, Los Angeles Stanley Carmichael Inception - Discovery Stage Research Projects iPS-Interneuron Transplantation for Neural Repair after Stroke $229,396
Stanford University Bertha Chen Inception - Discovery Stage Research Projects Autologous iPSC-based therapy for radiation induced bladder injury $235,836
University of California, San Diego Dionicio Siegel Inception - Discovery Stage Research Projects New Methods for the Chemical Expansion of Hematopoietic Stem and Progenitor Cells $232,200
Stanford University Philip Beachy Inception - Discovery Stage Research Projects Curing bladder cancer by replacing corrupted urothelium with differentiated hES cells $210,906
University of California, Berkeley Jacob Corn Inception - Discovery Stage Research Projects Genome editing for causation and reversion of MPN-associated mutations in human hematopoietic stem cells $235,800
University of California, Los Angeles Arjun Deb Inception - Discovery Stage Research Projects Targeting progenitors in scar tissue to reduce chronic scar burden $230,400
University of California, San Francisco Holger Willenbring Inception - Discovery Stage Research Projects Generation of bile duct-competent transplantable human liver organoids $206,460
Cedars-Sinai Medical Center Linda Cambier Inception - Discovery Stage Research Projects Exosomal Y-RNAs as mediators of bioactivity of cardiac-derived cell therapy $181,063
Cedars-Sinai Medical Center Clive Svendsen Inception - Discovery Stage Research Projects Blood Brain Barrier (BBB)-on-Chip: Development and validation of a novel iPS-based microfluidic model of the human BBB $241,992
Stanford University Phillip Yang Inception - Discovery Stage Research Projects Activation of patient-specific endogenous myocardial repair through the exosomes generated from the hypoxic iPSC-derived cardiomyocytes (iCMs). $234,619
University of California, Los Angeles Bennett Novitch Inception - Discovery Stage Research Projects Organoid Modeling of Human Cortical Microcircuits $208,916
International Society for Experimental Hematology David Traver Conference II International Society for Experimental Hematology, 45th Annual Scientific Meeting $25,000
American Association of Blood Banks Naynesh Kamani Conference II 14th International Cord Blood Symposium: Give Life Twice $15,000
Keystone Symposia on Molecular and Cellular Biology Thale Jarvis Conference II Neurogenesis during Development and in the Adult Brain (joint with Transcriptional and Epigenetic Control in Stem Cells) $35,000
University of California, Irvine LESLIE Thompson Conference II HD-CARE INAUGURAL SYMPOSIUM $1,500
City of Hope, Beckman Research Institute Yanhong Shi Therapeutic Translational Research Projects Process development for establishing an iPSC-based therapeutic candidate for Canavan disease $7,377,384
Capricor, Inc Linda Marban Clinical Trial Stage Projects Allogeneic Cardiosphere-Derived Cells for Duchenne Muscular Dystrophy Cardiomyopathy $3,376,259
University of California, Los Angeles Lili Yang Therapeutic Translational Research Projects Stem Cell-Based iNKT Cell Therapy for Cancer $6,956,775
University of California, San Diego Lawrence Goldstein Therapeutic Translational Research Projects Human Embryonic Stem Cell-Derived Neural Stem Cell Transplants in Amyotrophic Lateral Sclerosis $1,790,000
Semma Therapeutics Felicia Pagliuca Therapeutic Translational Research Projects Personalized Cell Therapy for Diabetes $597,333
University of California, San Francisco Jennifer Puck Late Stage Preclinical Projects Ex Vivo Transduction of the Human Artemis (DCLRE1C) cDNA by Lentiviral Vector AProArt into CD34+ Hematopoietic Cells for Artemis (ART)-Deficient Severe Combined Immunodeficiency (SCID) $4,268,865
University of California, Los Angeles Peter Butler Therapeutic Translational Research Projects Personalized Cell Therapy for Diabetes $1,494,896
Children's Hospital of Los Angeles Tracy Grikscheit Therapeutic Translational Research Projects ASCENT- Advanced Stem Cell Enteric Neuropathy Therapy $7,077,352
University of California, Davis Joseph Anderson Therapeutic Translational Research Projects Overexpression of HexA/HexB by lentivector expression in blood cells to treat Tay-Sachs and Sandhoff disease $883,174
Mosaic Event Management, Inc. Ron Johnson Conference - Manage The 2016 Bridges And SPARK Annual Meetings 2016 CIRM Bridges & SPARK Meetings $205,388
Angiocrine Bioscience, Inc. Paul Finnegan Late Stage Preclinical Projects Development of AB-110: genetically-modified endothelial cells plus expanded cord blood hematopoietic stem cells as a transplantation therapy $3,797,117
University of California, San Diego Catriona Jamieson Conference - The 2016 Alpha Stem Cell Clinic Annual Symposium UCSD Division of Regenerative Medicine and CIRM Alpha Clinics Network Symposium $37,778
San Francisco State University Lily Chen Bridges CIRM Bridges 2.0: Training the Next Generation of Stem Cell Scientists $3,041,625
SJSU Research Foundation Tzvia Abramson Bridges SCILL- Stem Cell Internships in Laboratory-based Learning $3,086,302
Humboldt State University Sponsored Programs Foundation Jacob Varkey Bridges CIRM 2.0 Bridges Training Program $2,534,223
Pasadena City College Pamela Eversole-Cire Bridges Bridges to Stem Cell Research and Therapy at Pasadena City College $2,522,591
City College Of San Francisco Carin Zimmerman Bridges Stem Cell Training Enhancement Program with a focus on Translational Research $1,978,247
The University Corporation at California State University, Northridge Cindy Malone Bridges Stem Cell Scientist Training Program $2,760,691
Cal State Univ, San Bernadino Nicole Bournias-Vardiabasis Bridges Stem Cell Scholars- from Basic Research to Clinical Translation: training a diverse pool of students in the lab, engaging them in patient and healthcare activities, motivating them to educate their immediate community and enabling them for careers in ... $2,659,136
City of Hope, Beckman Research Institute Paul Salvaterra SPARK SPARK Award Program in Stem Cell Biology for California High School Students $241,080
UCSF Benioff Children’s Hospital Oakland Ellen Fung SPARK Leveraging Investment in hiGHschool Training: Summer Program to Accelerate Regenerative medicine Knowledge (LIGHT a SPARK) $228,940
California State University San Marcos Corporation Bianca Mothe Bridges CIRM Bridges to Stem Cell Research and Therapy Training Grant $2,936,474
Cedars-Sinai Medical Center Wafa Tawackoli SPARK Mentored High School Summer Research Program $305,281

Pages

Icon for XLSX export